<DOC>
	<DOCNO>NCT00000766</DOCNO>
	<brief_summary>To assess safety efficacy three therapeutic regimen ( foscarnet , ganciclovir , combination ) recurrent persistent AIDS-related cytomegalovirus ( CMV ) retinitis . Although therapy foscarnet ganciclovir halt retinitis progression 90 percent patient treat , relapse common may accelerate due development drug resistance , deteriorate immune function , factor . Treatment strategy currently investigate include switch patient one drug combine two drug .</brief_summary>
	<brief_title>CMV Retinitis Retreatment Trial</brief_title>
	<detailed_description>Although therapy foscarnet ganciclovir halt retinitis progression 90 percent patient treat , relapse common may accelerate due development drug resistance , deteriorate immune function , factor . Treatment strategy currently investigate include switch patient one drug combine two drug . Patients randomize receive foscarnet , ganciclovir , combination two drug ( administer sequentially ) . Initially , patient undergo single multiple cycle induction therapy 14 day follow maintenance therapy . Patients retinitis continue progress intolerant initial treatment switch alternative drug cycle induction maintenance . Patients combination arm retinitis continue progress give cycle combination increase dose , , one drug cause toxicity , give cycle alternative drug . Patients follow monthly 6 month every 3 month thereafter .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Foscarnet</mesh_term>
	<mesh_term>Phosphonoacetic Acid</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Required : At least 28 day prior foscarnet ganciclovir . Concurrent Medication : Allowed : GCSF . Recommended : Antiretroviral therapy . Patients must : HIV infection AIDS . Active CMV retinitis 28 day either foscarnet ganciclovir therapy . At least one lesion onequarter disk area photograph . Visual acuity 3 letter ETDRS chart ( 5/200 Snellen ) affect eye . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Media opacity severe enough preclude visualization fundus . Retinal detachment schedule surgical repair . Patients follow prior condition exclude : History intolerance ganciclovir foscarnet sufficient contraindicate use . History combination foscarnet/ganciclovir therapy . Active drug alcohol abuse sufficient prevent compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Retinitis</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Foscarnet</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>